To test if degradation via the proteasome influences ACE2 levels and thereby SARS-CoV-2 uptake, we treated A549-ACE2 cells with the proteasome inhibitor (MG132) and monitored SARS-CoV2 replication. However, proteasomal inhibition impaired SARS-CoV-2 replication, indicating that proteasomal activity...